Forum Diabetologicum - Issue Supplementum 1/2022
Editorial
6
15
Forum Diabetologicum
2022 Číslo Supplementum 1
Najčítanejšie v tomto čísle
- Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)
- Rationalisation of previous multiple insulin treatment by switching to a fixed combination of basal insulin degludec and the GLP1-receptor agonist liraglutide (IDegLira): results of the SIMPLIFY study after 14 weeks
- Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)
- Simplification of previous multiple insulin treatment by switching to a fixed combination of basal insulin degludec and GLP1-receptor agonist liraglutide: SIMPLIFY study Evaluation of the early outcome questionnaires